Firmenbeschreibung
Moderna Inc. ist ein US amerikanisches Biotech-Unternehmen, das sich auf die Forschung und Entwicklung von Arzneimitteln auf Basis von mRNA spezialisiert. mRNA-Arzneien sind darauf ausgelegt, dass körpereigene Zellen Proteine mit therapeutischer oder vorbeugender Wirkung produzieren, die bei der Behandlung einer Vielzahl von Krankheiten helfen können. Die Anwendungsgebiete für mRNA-Produkte umfassen Therapeutika und Impfstoffe für Krebsimmuntherapien, seltene Krankheiten, Herz-Kreislauf-Erkrankungen, Autoimmunerkrankungen und Entzündungen. Die beständigen Fortschritte des Unternehmens in der Grundlagen- und angewandten mRNA-Forschung ermöglichen parallele Neuentwicklungen, sowohl unabhängig als auch mit strategischen Partnern zusammen. Es bestehen strategische Partnerschaften mit AstraZeneca PLC und Merck & Co., außerdem mit verschiedenen US-Behörden und Forschungseinrichtungen.
KeyData
endOfFinancialYear: | 31.12.2024 00:00 |
stockholderStructure: | BAILLIE GIFFORD CO (11.9128%),Vanguard Group (8.84748%),BlackRock Inc. (6.60205%),State Street Corporation (3.81582%),Flagship Pioneering Inc. (2.52219%),Theleme Partners LLP (1.91772%),Wellington Management Group (1.88539%),GEODE CAPITAL MANAGEMENT LLC (1.70897%),FMR LLC. (1.66824%),Goldman Sachs Group Inc. (1.18767%) |
sharesOutstanding: | 384817811.0000 |
ceo: | Stéphane Bancel |
board: | Jamey Mock, Stephen Hoge, M.D., Jerh Collins, Ph.D., Kate Cronin, Tracey Franklin, Shannon Thyme Klinger, Brad Miller |
supervisoryBoard: | Dr. Noubar Afeyan, Stéphane Bancel, Sandra Horning, M.D., Abbas Hussain, Elizabeth Nabel, M.D., François Nader, M.D., David Rubenstein, Paul Sagan, Elizabeth Tallett, Henri A. Termeer |
countryID: | 20 |
faceValue: | 0.0001 |
faceValueCurrencyID: | 4 |
faceValueCurrency: | USD |
sectorName: | Biotechnologie |
industryName: | Biotechnologie |
subsectorName: | Biotechnologie |
country: | USA |
countryName: | USA |
Kontakt
email: | IR@modernatx.com |
irWebSite: | https://investors.modernatx.com/ |
Adresse
street: | 200 Technology Square |
city: | Cambridge, Massachusetts 02139, USA |
phone: | +1-617-714-6500 |
fax: | +1-617-583-1998 |
webSite: | https://www.modernatx.com/ |
email: | info@modernatx.com |
Finanzen (kurz)
year: | 2021 | cash: | 6848.0000 |
balanceSheetTotal: | 24669.0000 | liabilities: | 10524.0000 |
totalShareholdersEquity: | 14145.0000 | sales: | 18471.0000 |
investment: | 18.0000 | incomeBeforeTaxes: | 13285.0000 |
netIncome: | 12202.0000 | cashFlow: | 4224.0000 |
employees: | 2700 | currencyID: | 4 |
units: | 1000000 | currency: | USD |
year: | 2022 | cash: | 3205.0000 |
balanceSheetTotal: | 25858.0000 | liabilities: | 6735.0000 |
totalShareholdersEquity: | 19123.0000 | sales: | 19263.0000 |
incomeBeforeTaxes: | 9575.0000 | netIncome: | 8362.0000 |
cashFlow: | -3643.0000 | currencyID: | 4 |
units: | 1000000 | currency: | USD |
year: | 2023 | cash: | 2907.0000 |
balanceSheetTotal: | 18426.0000 | liabilities: | 4572.0000 |
shareCapital: | 0.0000 | totalShareholdersEquity: | 13854.0000 |
sales: | 6848.0000 | incomeBeforeTaxes: | -3942.0000 |
netIncome: | -4714.0000 | cashFlow: | -289.0000 |
currencyID: | 4 | units: | 1000000 |
currency: | USD |
Finanzen (kurz)
year: | 2021 |
cash: | 6848.0000 |
balanceSheetTotal: | 24669.0000 |
liabilities: | 10524.0000 |
totalShareholdersEquity: | 14145.0000 |
sales: | 18471.0000 |
investment: | 18.0000 |
incomeBeforeTaxes: | 13285.0000 |
netIncome: | 12202.0000 |
cashFlow: | 4224.0000 |
employees: | 2700 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
year: | 2022 |
cash: | 3205.0000 |
balanceSheetTotal: | 25858.0000 |
liabilities: | 6735.0000 |
totalShareholdersEquity: | 19123.0000 |
sales: | 19263.0000 |
incomeBeforeTaxes: | 9575.0000 |
netIncome: | 8362.0000 |
cashFlow: | -3643.0000 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
year: | 2023 |
cash: | 2907.0000 |
balanceSheetTotal: | 18426.0000 |
liabilities: | 4572.0000 |
shareCapital: | 0.0000 |
totalShareholdersEquity: | 13854.0000 |
sales: | 6848.0000 |
incomeBeforeTaxes: | -3942.0000 |
netIncome: | -4714.0000 |
cashFlow: | -289.0000 |
currencyID: | 4 |
units: | 1000000 |
currency: | USD |
Finanzen (ausführlich)
year: | 2022 | units: | 1000000 |
balanceSheetTotal: | 25858.0000 | cash: | 3205.0000 |
currentAssets: | 13431.0000 | fixedAssets: | 12427.0000 |
liabilities: | 4923.0000 | totalLiabilitiesEquity: | 25858.0000 |
totalShareholdersEquity: | 19123.0000 | property: | 2018.0000 |
longTermInvestments: | 8318.0000 | inventories: | 949.0000 |
accountsReceivable: | 1385.0000 | accountsPayable: | 487.0000 |
liabilitiesTotal: | 6735.0000 | longTermDebt: | 912.0000 |
sales: | 19263.0000 | netIncome: | 8362.0000 |
operatingResult: | 9420.0000 | incomeInterest: | 200.0000 |
investments: | 3295.0000 | incomeTaxes: | 1213.0000 |
costGoodsSold: | 5416.0000 | grossProfit: | 13847.0000 |
cashFlow: | 4981.0000 | cashFlowInvesting: | -5176.0000 |
cashFlowFinancing: | -3448.0000 | cashFlowTotal: | -3643.0000 |
accountingStandard: | US GAAP | equityRatio: | 73.9539 |
debtEquityRatio: | 0.0477 | liquidityI: | 0.6510 |
liquidityII: | 0.9324 | netMargin: | 43.4096 |
grossMargin: | 71.8839 | cashFlowMargin: | 25.8579 |
ebitMargin: | 48.9020 | ebitdaMargin: | 0.0000 |
preTaxROE: | 50.0706 | preTaxROA: | 37.0292 |
roe: | 43.7274 | roa: | 32.3382 |
netIncomeGrowth: | -31.4703 | revenuesGrowth: | 4.2878 |
taxExpenseRate: | 12.6684 | equityTurnover: | 1.0073 |
epsBasic: | 21.2600 | epsDiluted: | 20.1200 |
epsBasicGrowth: | -29.8581 | incomeBeforeTaxes: | 9575.0000 |
priceEarningsRatioCompany: | 8.4487 | priceCashFlowRatio: | 13.9318 |
bookValuePerShare: | 49.4979 | marketCap: | 69394317874.2800 |
earningsYield: | 11.8361 | pegRatio: | -0.2830 |
cashFlowPerShare: | 12.8928 | priceBookValueRatio: | 3.6288 |
priceEarningsRatio: | 8.2988 | netEarningsPerShare: | 21.6442 |
currency: | USD |
year: | 2023 | units: | 1000000 |
balanceSheetTotal: | 18426.0000 | cash: | 2907.0000 |
currentAssets: | 10325.0000 | fixedAssets: | 8101.0000 |
liabilities: | 3015.0000 | totalLiabilitiesEquity: | 18426.0000 |
totalShareholdersEquity: | 13854.0000 | property: | 1945.0000 |
longTermInvestments: | 4677.0000 | inventories: | 202.0000 |
accountsReceivable: | 892.0000 | accountsPayable: | 520.0000 |
liabilitiesTotal: | 4572.0000 | longTermDebt: | 575.0000 |
commonStock: | 0.0000 | preferredStock: | 0.0000 |
sales: | 6848.0000 | netIncome: | -4714.0000 |
operatingResult: | -4239.0000 | incomeInterest: | 421.0000 |
investments: | 4845.0000 | incomeTaxes: | 772.0000 |
costGoodsSold: | 4693.0000 | grossProfit: | 2155.0000 |
cashFlow: | -3118.0000 | cashFlowInvesting: | 4206.0000 |
cashFlowFinancing: | -1377.0000 | cashFlowTotal: | -289.0000 |
accountingStandard: | US GAAP | equityRatio: | 75.1872 |
debtEquityRatio: | 0.0415 | liquidityI: | 0.9642 |
liquidityII: | 1.2600 | netMargin: | -68.8376 |
grossMargin: | 31.4690 | cashFlowMargin: | -45.5315 |
ebitMargin: | -61.9013 | ebitdaMargin: | 0.0000 |
preTaxROE: | -28.4539 | preTaxROA: | -21.3937 |
roe: | -34.0263 | roa: | -25.5834 |
netIncomeGrowth: | -156.3741 | revenuesGrowth: | -64.4500 |
taxExpenseRate: | -19.5840 | equityTurnover: | 0.4943 |
epsBasic: | -12.3300 | epsDiluted: | -12.3300 |
epsBasicGrowth: | -157.9962 | shareCapital: | 0.0000 |
incomeBeforeTaxes: | -3942.0000 | priceCashFlowRatio: | -12.1864 |
bookValuePerShare: | 36.2601 | marketCap: | 37997180535.6000 |
earningsYield: | -12.3982 | cashFlowPerShare: | -8.1607 |
priceBookValueRatio: | 2.7427 | netEarningsPerShare: | -12.3379 |
currency: | USD |
year: | 2024 | priceCashFlowRatio: | -5.2618 |
bookValuePerShare: | 36.2601 | marketCap: | 16524076804.3400 |
earningsYield: | -28.7145 | pegRatio: | 0.0220 |
cashFlowPerShare: | -8.1607 | netAssetsPerShare: | 36.2601 |
priceBookValueRatio: | 1.1842 | netEarningsPerShare: | -12.3379 |
currency: | USD |
Finanzen (ausführlich)
year: | 2022 |
units: | 1000000 |
balanceSheetTotal: | 25858.0000 |
cash: | 3205.0000 |
currentAssets: | 13431.0000 |
fixedAssets: | 12427.0000 |
liabilities: | 4923.0000 |
totalLiabilitiesEquity: | 25858.0000 |
totalShareholdersEquity: | 19123.0000 |
property: | 2018.0000 |
longTermInvestments: | 8318.0000 |
inventories: | 949.0000 |
accountsReceivable: | 1385.0000 |
accountsPayable: | 487.0000 |
liabilitiesTotal: | 6735.0000 |
longTermDebt: | 912.0000 |
sales: | 19263.0000 |
netIncome: | 8362.0000 |
operatingResult: | 9420.0000 |
incomeInterest: | 200.0000 |
investments: | 3295.0000 |
incomeTaxes: | 1213.0000 |
costGoodsSold: | 5416.0000 |
grossProfit: | 13847.0000 |
cashFlow: | 4981.0000 |
cashFlowInvesting: | -5176.0000 |
cashFlowFinancing: | -3448.0000 |
cashFlowTotal: | -3643.0000 |
accountingStandard: | US GAAP |
equityRatio: | 73.9539 |
debtEquityRatio: | 0.0477 |
liquidityI: | 0.6510 |
liquidityII: | 0.9324 |
netMargin: | 43.4096 |
grossMargin: | 71.8839 |
cashFlowMargin: | 25.8579 |
ebitMargin: | 48.9020 |
ebitdaMargin: | 0.0000 |
preTaxROE: | 50.0706 |
preTaxROA: | 37.0292 |
roe: | 43.7274 |
roa: | 32.3382 |
netIncomeGrowth: | -31.4703 |
revenuesGrowth: | 4.2878 |
taxExpenseRate: | 12.6684 |
equityTurnover: | 1.0073 |
epsBasic: | 21.2600 |
epsDiluted: | 20.1200 |
epsBasicGrowth: | -29.8581 |
incomeBeforeTaxes: | 9575.0000 |
priceEarningsRatioCompany: | 8.4487 |
priceCashFlowRatio: | 13.9318 |
bookValuePerShare: | 49.4979 |
marketCap: | 69394317874.2800 |
earningsYield: | 11.8361 |
pegRatio: | -0.2830 |
cashFlowPerShare: | 12.8928 |
priceBookValueRatio: | 3.6288 |
priceEarningsRatio: | 8.2988 |
netEarningsPerShare: | 21.6442 |
currency: | USD |
year: | 2023 |
units: | 1000000 |
balanceSheetTotal: | 18426.0000 |
cash: | 2907.0000 |
currentAssets: | 10325.0000 |
fixedAssets: | 8101.0000 |
liabilities: | 3015.0000 |
totalLiabilitiesEquity: | 18426.0000 |
totalShareholdersEquity: | 13854.0000 |
property: | 1945.0000 |
longTermInvestments: | 4677.0000 |
inventories: | 202.0000 |
accountsReceivable: | 892.0000 |
accountsPayable: | 520.0000 |
liabilitiesTotal: | 4572.0000 |
longTermDebt: | 575.0000 |
commonStock: | 0.0000 |
preferredStock: | 0.0000 |
sales: | 6848.0000 |
netIncome: | -4714.0000 |
operatingResult: | -4239.0000 |
incomeInterest: | 421.0000 |
investments: | 4845.0000 |
incomeTaxes: | 772.0000 |
costGoodsSold: | 4693.0000 |
grossProfit: | 2155.0000 |
cashFlow: | -3118.0000 |
cashFlowInvesting: | 4206.0000 |
cashFlowFinancing: | -1377.0000 |
cashFlowTotal: | -289.0000 |
accountingStandard: | US GAAP |
equityRatio: | 75.1872 |
debtEquityRatio: | 0.0415 |
liquidityI: | 0.9642 |
liquidityII: | 1.2600 |
netMargin: | -68.8376 |
grossMargin: | 31.4690 |
cashFlowMargin: | -45.5315 |
ebitMargin: | -61.9013 |
ebitdaMargin: | 0.0000 |
preTaxROE: | -28.4539 |
preTaxROA: | -21.3937 |
roe: | -34.0263 |
roa: | -25.5834 |
netIncomeGrowth: | -156.3741 |
revenuesGrowth: | -64.4500 |
taxExpenseRate: | -19.5840 |
equityTurnover: | 0.4943 |
epsBasic: | -12.3300 |
epsDiluted: | -12.3300 |
epsBasicGrowth: | -157.9962 |
shareCapital: | 0.0000 |
incomeBeforeTaxes: | -3942.0000 |
priceCashFlowRatio: | -12.1864 |
bookValuePerShare: | 36.2601 |
marketCap: | 37997180535.6000 |
earningsYield: | -12.3982 |
cashFlowPerShare: | -8.1607 |
priceBookValueRatio: | 2.7427 |
netEarningsPerShare: | -12.3379 |
currency: | USD |
year: | 2024 |
priceCashFlowRatio: | -5.2618 |
bookValuePerShare: | 36.2601 |
marketCap: | 16524076804.3400 |
earningsYield: | -28.7145 |
pegRatio: | 0.0220 |
cashFlowPerShare: | -8.1607 |
netAssetsPerShare: | 36.2601 |
priceBookValueRatio: | 1.1842 |
netEarningsPerShare: | -12.3379 |
currency: | USD |